Abbot Financial Management, Inc. Pfizer Inc Transaction History

Abbot Financial Management, Inc.

$229 Million
Q3 2025

A detailed history of Abbot Financial Management, Inc. transactions in Pfizer Inc stock. As of the latest transaction made, Abbot Financial Management, Inc. holds 21,010 shares of PFE stock, worth $526,930. This represents 0.23% of its overall portfolio holdings.

Number of Shares

21,010

Previous 23,067 8.92%

Holding current value

$526,930

Previous $559,000 4.29%

% of portfolio

0.23%

Previous 0.26%

32 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 10, 2025	SELL	$23.29 - $25.88 $47,907 - $53,235	-2,057 Reduced 8.92%	21,010 $535,000
Q2 2025 Aug 14, 2025	SELL	$21.59 - $24.84 $19,927 - $22,927	-923 Reduced 3.85%	23,067 $559,000
Q1 2025 May 07, 2025	SELL	$25.01 - $27.13 $45,568 - $49,430	-1,822 Reduced 7.06%	23,990 $607,000
Q4 2024 Feb 06, 2025	SELL	$24.8 - $30.19 $271,212 - $330,157	-10,936 Reduced 29.76%	25,812 $684,000
Q3 2024 Nov 08, 2024	BUY	$27.7 - $31.39 $12,326 - $13,968	445 Added 1.23%	36,748 $1.06 Million
Q2 2024 Aug 09, 2024	SELL	$25.26 - $29.6 $32,459 - $38,036	-1,285 Reduced 3.42%	36,303 $1.02 Million
Q1 2024 May 13, 2024	SELL	$25.89 - $29.73 $149,255 - $171,393	-5,765 Reduced 13.3%	37,588 $1.04 Million
Q4 2023 Feb 09, 2024	SELL	$26.13 - $33.94 $15,625 - $20,296	-598 Reduced 1.36%	43,353 $1.25 Million
Q3 2023 Nov 13, 2023	SELL	$32.09 - $37.51 $144,212 - $168,569	-4,494 Reduced 9.28%	43,951 $1.46 Million
Q2 2023 Aug 14, 2023	SELL	$36.12 - $41.79 $69,205 - $80,069	-1,916 Reduced 3.8%	48,445 $1.78 Million
Q1 2023 May 15, 2023	SELL	$39.39 - $51.28 $179,027 - $233,067	-4,545 Reduced 8.28%	50,361 $2.05 Million
Q4 2022 Feb 09, 2023	SELL	$41.75 - $54.5 $98,697 - $128,838	-2,364 Reduced 4.13%	54,906 $2.81 Million
Q3 2022 Nov 14, 2022	SELL	$43.76 - $53.42 $32,601 - $39,797	-745 Reduced 1.28%	57,270 $2.51 Million
Q2 2022 Aug 09, 2022	SELL	$46.53 - $55.17 $4,513 - $5,351	-97 Reduced 0.17%	58,015 $3.04 Million
Q1 2022 May 12, 2022	SELL	$45.75 - $56.69 $68,396 - $84,751	-1,495 Reduced 2.51%	58,112 $3.01 Million
Q4 2021 Feb 15, 2022	SELL	$41.32 - $61.25 $13,222 - $19,600	-320 Reduced 0.53%	59,607 $3.52 Million
Q3 2021 Nov 04, 2021	BUY	$39.25 - $50.42 $2,158 - $2,773	55 Added 0.09%	59,927 $2.58 Million
Q2 2021 Aug 05, 2021	SELL	$35.91 - $40.68 $17,811 - $20,177	-496 Reduced 0.82%	59,872 $2.35 Million
Q1 2021 May 13, 2021	SELL	$33.49 - $37.77 $209,011 - $235,722	-6,241 Reduced 9.37%	60,368 $2.19 Million
Q4 2020 Feb 11, 2021	SELL	$33.47 - $42.56 $6,694 - $8,512	-200 Reduced 0.3%	66,609 $2.45 Million
Q3 2020 Oct 26, 2020	BUY	$31.75 - $37.25 $36,639 - $42,986	1,154 Added 1.76%	66,809 $2.45 Million
Q2 2020 Jul 22, 2020	BUY	$30.12 - $36.54 $10,542 - $12,789	350 Added 0.54%	65,655 $2.15 Million
Q1 2020 May 12, 2020	SELL	$27.03 - $38.62 $25,678 - $36,689	-950 Reduced 1.43%	65,305 $2.13 Million
Q4 2019 Feb 12, 2020	BUY	$32.92 - $37.36 $19,752 - $22,416	600 Added 0.91%	66,255 $2.6 Million
Q3 2019 Nov 13, 2019	SELL	$32.49 - $42.13 $73,102 - $94,792	-2,250 Reduced 3.31%	65,655 $2.36 Million
Q2 2019 Aug 08, 2019	SELL	$36.98 - $41.52 $16,641 - $18,684	-450 Reduced 0.66%	67,905 $2.94 Million
Q1 2019 May 15, 2019	BUY	$37.5 - $41.2 $9,375 - $10,300	250 Added 0.37%	68,355 $2.9 Million
Q4 2018 Feb 07, 2019	SELL	$38.47 - $43.86 $32,314 - $36,842	-840 Reduced 1.22%	68,105 $2.97 Million
Q3 2018 Nov 09, 2018	SELL	$34.47 - $41.81 $63,149 - $76,595	-1,832 Reduced 2.59%	68,945 $3.04 Million
Q1 2018 May 02, 2018	BUY	$31.91 - $37.02 $44,674 - $51,828	1,400 Added 2.02%	70,777 $2.51 Million
Q4 2017 Feb 13, 2018	SELL	$33.26 - $35.29 $2,561 - $2,717	-77 Reduced 0.11%	69,377 $2.51 Million
Q3 2017 Oct 25, 2017	BUY	$31.0 - $34.15 $2.15 Million - $2.37 Million	69,454	69,454 $2.52 Million

Others Institutions Holding PFE

# of Institutions

3,354

Shares Held

3.57B

Call Options Held

87.2M

Put Options Held

106M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $141B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Abbot Financial Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Abbot Financial Management, Inc. with notifications on news.

Account

Abbot Financial Management, Inc. Pfizer Inc Transaction History